GlassScriptPhysician profile
Kelly O'Shea
NPI 1255951299
$808.57
in general payments reported to CMS, 2019-2025
14 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $123 · 2024: $381 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $685.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $157.50 | 2024 | Tisseel |
| Gynesonics, INC. | $143.11 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $122.65 | 2022 | |
| Coopersurgical, INC. | $120.17 | 2025 | Ally II Ups |
| Biogen, INC. | $85.38 | 2025 | Zurzuvae |
| Intuitive Surgical, INC. | $46.00 | 2025 | |
| Mayne Pharma Commercial LLC | $21.02 | 2025 | |
| Pfizer INC. | $20.05 | 2024 | |
| Astellas Pharma US INC | $18.54 | 2024 | Veozah |
| Organon LLC | $17.57 | 2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $15.48 | 2024 | Myfembree |
| Exact Sciences Corporation | $14.51 | 2025 | Cologuard Collection Kit |
| Radius Health, INC. | $13.46 | 2024 | Tymlos |
| Exeltis, USA INC. | $13.13 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly O'Shea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.